On the contrary, blood type was not associated with pancreatic cancer survival among 488 Chinese cases [20], and ABO variants were not associated with survival among 1,028 cases from the PANcreatic Disease ReseArch (PANDoRA) consortium, although analysis was not adjusted for clinical covariates [6]. The gene discussed is ABO; the disease is familial pancreatic carcinoma.